Carlyle Acquires Knack RCM and EqualizeRCM
Analysis based on 19 articles · First reported May 04, 2026 · Last updated May 04, 2026
The acquisition by The Carlyle Group is expected to enhance operational scale and diversification in the healthcare RCM market, potentially leading to increased efficiency and advanced AI capabilities for healthcare providers. This consolidation reflects a growing trend in the industry, which could impact other RCM providers and healthcare technology companies.
The Carlyle Group, a global investment firm, announced on May 4, 2026, its acquisition of a majority stake in two U.S. healthcare revenue cycle management (RCM) providers, Knack RCM and EqualizeRCM. This strategic move aims to establish an AI-native, global, multi-specialty RCM platform. Both Knack RCM and EqualizeRCM are complementary providers serving various healthcare segments, including physician groups, rural hospitals, and durable medical equipment providers. The combined entity is expected to leverage AI capabilities, expand its global delivery footprint across the United States, India, and the Philippines, and strengthen leadership. Founders Rajiv Sharma of Knack RCM and Nagi Rao of EqualizeRCM will remain invested in the new platform. The Carlyle Group intends to further build on this platform strategy by pursuing additional synergistic opportunities within the RCM industry.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard